Association between changes in thioredoxin reductase and other peripheral blood biomarkers with response to PD-1 inhibitor-based combination immunotherapy in non-small cell lung cancer: a retrospective study
Shaodi Wen(Jiangsu Cancer Hospital), Bo Shen(Jiangsu Cancer Hospital), Gianluca Spitaleri(Institute of Oncology Research), Ruotong Wang(Jiangsu Cancer Hospital), Paul Hofman(Inserm), Xin Wang(Nanjing Medical University), Yuzhong Chen(Bengbu Medical College), Xiaoyue Du(Inner Mongolia Agricultural University), Miaolin Zhu(Jiangsu Cancer Hospital), Paolo Bironzo(University of Turin), Jingwei Xia(Jiangsu Cancer Hospital), Weiwei Peng(Ganzhou People's Hospital)
Cited by 12
Related Papers
A synonymous variant in IRGM alters a binding site for miR-196 and causes deregulation of IRGM-dependent xenophagy in Crohn's disease
|Nature Genetics|2011|563
The Extracellular Signal–Regulated Kinase Isoform ERK1 Is Specifically Required for In Vitro and In Vivo Adipogenesis
|Diabetes|2005|334
Grain yield prediction of rice using multi-temporal UAV-based RGB and multispectral images and model transfer – a case study of small farmlands in the South of China
|Agricultural and Forest Meteorology|2020|299
HERTHENA-Lung01, a Phase II Trial of Patritumab Deruxtecan (HER3-DXd) in Epidermal Growth Factor Receptor–Mutated Non–Small-Cell Lung Cancer After Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Therapy and Platinum-Based Chemotherapy
|Journal of Clinical Oncology|2023|224
Comutations and KRASG12C Inhibitor Efficacy in Advanced NSCLC
|Cancer Discovery|2023|190